Feature

Enthesitis, arthritis, tenosynovitis linked to dupilumab use for atopic dermatitis

Publish date: June 1, 2023

 

FROM ARTHRITIS & RHEUMATOLOGY

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Topical delgocitinib shows promise for chronic hand eczema, pivotal trial shows
MDedge Family Medicine
JAK inhibitor ivarmacitinib shows efficacy for atopic dermatitis in a pivotal trial
MDedge Family Medicine
What are the clinical implications of recent skin dysbiosis discoveries?
MDedge Family Medicine
Study focuses on adolescent data in upadacitinib AD trials
MDedge Family Medicine
Can this tool forecast peanut allergies?
MDedge Family Medicine
Facial, hand, and foot dermatitis: Lebrikizumab and dupilumab show efficacy in new studies
MDedge Family Medicine
Expunging ‘penicillin allergy’: Your questions answered
MDedge Family Medicine
AD in infancy: Diagnostic advice and treatment tips
MDedge Family Medicine
Can online mindfulness and self-compassion training improve quality of life for patients with atopic dermatitis?
MDedge Family Medicine
JAK-inhibitor safety in adolescents with AD: Long-term analyses reported
MDedge Family Medicine